Cargando…
A Small Peptide Increases Drug Delivery in Human Melanoma Cells
Melanoma is the most fatal type of skin cancer and is notoriously resistant to chemotherapies. The response of melanoma to current treatments is difficult to predict. To combat these challenges, in this study, we utilize a small peptide to increase drug delivery to melanoma cells. A peptide library...
Autores principales: | Tong, Shirley, Darwish, Shaban, Ariani, Hanieh Hossein Nejad, Lozada, Kate Alison, Salehi, David, Cinelli, Maris A., Silverman, Richard B., Kaur, Kamaljit, Yang, Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145755/ https://www.ncbi.nlm.nih.gov/pubmed/35631623 http://dx.doi.org/10.3390/pharmaceutics14051036 |
Ejemplares similares
-
Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells
por: Hossein-Nejad-Ariani, Hanieh, et al.
Publicado: (2019) -
Inhibition of interferon-gamma-stimulated melanoma progression by targeting neuronal nitric oxide synthase (nNOS)
por: Tong, Shirley, et al.
Publicado: (2022) -
Bis-Cinnamamide Derivatives as APE/Ref-1 Inhibitors for the Treatment of Human Melanoma
por: Alhazmi, Razan, et al.
Publicado: (2022) -
Disabling the Nuclear Translocalization of RelA/NF-κB by a Small Molecule Inhibits Triple-Negative Breast Cancer Growth
por: Kanzaki, Hirotaka, et al.
Publicado: (2021) -
Synthesis and Characterization of a New Peptide Prodrug of Glucosamine with Enhanced Gut Permeability
por: Gilzad Kohan, Hamed, et al.
Publicado: (2015)